81. 先天性副腎皮質酵素欠損症 Congenital adrenal hyperplasia Clinical trials / Disease details

臨床試験数 : 87 / 薬物数 : 87 - (DrugBank : 23) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 68

20 trials found

diseases per page:

Showing 1 to 10 of 20 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-004381-19-DE (EUCTR)	16/12/2021	09/04/2021	Study to Evaluate the Safety and Efficacy of Crinecerfont in Pediatric Patients With Classic Congeni ...	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecer ...	Classic Congenital Adrenal Hyperplasia (CAH) MedDRA version: 20.0;Level: LLT;Classification code 100 ...	Product Name: Crinecerfont Product Code: NBI-74788 INN or Proposed INN: Crinecerfont Product Name: Crin ...	Neurocrine Biosciences, Inc.	NULL	Not Recruiting			Female: yes Male: yes	81	Phase 3	France;United States;Greece;Canada;Spain;Poland;Belgium;Germany;United Kingdom;Italy;Sweden
2	EUCTR2020-004381-19-IT (EUCTR)	13/10/2021	30/08/2021	Study to Evaluate the Safety and Efficacy of Crinecerfont in Pediatric Patients With Classic Congeni ...	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecer ...	Congenital adrenal hyperplasia (CAH) is a group of rare inherited endocrine disorders characterized ...	Product Name: Crinecerfont Product Code: [NBI-74788] Other descriptive name: Crinecerfont is a novel no ...	Neurocrine Biosciences, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	81	Phase 3	France;United States;Greece;Canada;Spain;Poland;Belgium;Germany;Italy;Sweden
3	EUCTR2020-004381-19-ES (EUCTR)	13/08/2021	13/08/2021	Study to Evaluate the Safety and Efficacy of Crinecerfont in Pediatric Patients With Classic Congeni ...	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecer ...	Classic Congenital Adrenal Hyperplasia (CAH) MedDRA version: 20.0;Level: LLT;Classification code 100 ...	Product Name: Crinecerfont Product Code: NBI-74788 INN or Proposed INN: Crinecerfont Product Name: Crin ...	Neurocrine Biosciences, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	81	Phase 3	France;United States;Greece;Canada;Poland;Belgium;Spain;Germany;Italy;Sweden
4	EUCTR2019-004873-17-NL (EUCTR)	20/07/2021	12/11/2020	A study of safety and efficacy of NBI-74788 in Classic Congenital Adrenal Hyperplasia	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecer ...	Classic Congenital Adrenal Hyperplasia (CAH) MedDRA version: 20.0;Level: LLT;Classification code 100 ...	Product Name: Crinecerfont Product Code: NBI-74788 INN or Proposed INN: Crinecerfont	Neurocrine Biosciences, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	165	Phase 3	Portugal;Serbia;United States;Czechia;Greece;Spain;Ukraine;Turkey;Austria;Israel;United Kingdom;Ital ...
5	NCT04806451 (ClinicalTrials.gov)	June 24, 2021	16/3/2021	Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Patients With Classic Con ...	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecer ...	Congenital Adrenal Hyperplasia	Drug: Crinecerfont;Drug: Placebo	Neurocrine Biosciences	NULL	Active, not recruiting	2 Years	17 Years	All	103	Phase 3	United States;Belgium;Canada;France;Germany;Greece;Italy;Poland;Spain;United Kingdom
6	EUCTR2020-004381-19-FR (EUCTR)	23/06/2021	21/04/2021	Study to Evaluate the Safety and Efficacy of Crinecerfont in Pediatric Patients With Classic Congeni ...	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecer ...	Classic Congenital Adrenal Hyperplasia (CAH) MedDRA version: 20.0;Level: LLT;Classification code 100 ...	Product Name: Crinecerfont Product Code: NBI-74788 INN or Proposed INN: Crinecerfont Product Name: Crin ...	Neurocrine Biosciences, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	81	Phase 3	United States;France;Greece;Canada;Spain;Poland;Belgium;Germany;Italy;Sweden
7	EUCTR2020-004381-19-GR (EUCTR)	07/06/2021	06/04/2021	Study to Evaluate the Safety and Efficacy of Crinecerfont in Pediatric Patients With Classic Congeni ...	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecer ...	Classic Congenital Adrenal Hyperplasia (CAH) MedDRA version: 20.0;Level: LLT;Classification code 100 ...	Product Name: Crinecerfont Product Code: NBI-74788 INN or Proposed INN: Crinecerfont Product Name: Crin ...	Neurocrine Biosciences, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	81	Phase 3	France;United States;Canada;Greece;Spain;Poland;Belgium;Germany;Italy;Sweden
8	EUCTR2019-004873-17-AT (EUCTR)	17/02/2021	07/10/2020	A study of safety and efficacy of NBI-74788 in Classic Congenital Adrenal Hyperplasia	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecer ...	Classic Congenital Adrenal Hyperplasia (CAH) MedDRA version: 20.0;Level: LLT;Classification code 100 ...	Product Name: Crinecerfont Product Code: NBI-74788 INN or Proposed INN: Crinecerfont	Neurocrine Biosciences, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	165	Phase 3	Portugal;Serbia;United States;Czechia;Greece;Spain;Ukraine;Turkey;Austria;Israel;United Kingdom;Ital ...
9	EUCTR2019-004873-17-DE (EUCTR)	15/01/2021	19/05/2020	A study of safety and efficacy of NBI-74788 in Classic Congenital Adrenal Hyperplasia	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecer ...	Classic Congenital Adrenal Hyperplasia (CAH) MedDRA version: 20.0;Level: LLT;Classification code 100 ...	Product Name: Crinecerfont Product Code: NBI-74788 INN or Proposed INN: Crinecerfont	Neurocrine Biosciences, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	165	Phase 3	Belgium;Poland;Bulgaria;Netherlands;Germany;Sweden;Czech Republic;Portugal;Serbia;United States;Czec ...
10	EUCTR2019-004873-17-BG (EUCTR)	17/12/2020	03/07/2020	A study of safety and efficacy of NBI-74788 in Classic Congenital Adrenal Hyperplasia	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecer ...	Classic Congenital Adrenal Hyperplasia (CAH) MedDRA version: 20.0;Level: LLT;Classification code 100 ...	Product Name: Crinecerfont Product Code: NBI-74788 INN or Proposed INN: Crinecerfont	Neurocrine Biosciences, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	165	Phase 3	United States;Portugal;Czechia;Greece;Spain;Austria;United Kingdom;Italy;France;Czech Republic;Belgi ...

First Previous1 2Next Last